Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ontario Clinical Oncology Group (OCOG)
With
U.S. Army Medical Research and Development Command
Supportive Cancer Care Research Unit
Our specific objectives are: (i) to develop computer and paper based versions of the Decision Boards for (a) chemotherapy for early stage breast cancer (chemotherapy versus no treatment), (b) mastectomy versus lumpectomy plus radiation and (ii) to compare the relative effectiveness of the computer and paper based versions with the standard Decision Board for patients with early breast cancer.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Chemotherapy Group:
Female
Histologically documented invasive carcinoma of the breast treated with modified radical mastectomy or lumpectomy
Axillary node dissection
Chemotherapy alone or in addition to tamoxifen as an appropriate treatment option
Surgery Group:
Female
Newly diagnosed carcinoma of the breast diagnosed either by cytology or pathological examination, OR if no biopsy, a strong clinical suspicion of malignancy
Clinical stage I or II disease
Candidate for breast conserving surgery
You may not be if
Chemotherapy Group:
Candidate for CEF chemotherapy
Clinical evidence of metastatic disease
Serious comorbidity that would preclude receiving chemotherapy treatment
Unable to speak or read English fluently (including visual impairment)
Mentally incompetent including any psychiatric or addictive disorders that would preclude shared decision-making
Surgery Group:
Previous surgery for breast cancer
Previous breast irradiation
Pregnant
Clinical suspicion of bilateral breast cancer
Serious comorbidity that would preclude definitive surgery
Unable to speak or read English fluently (including visual impairment)
Mentally incompetent including any psychiatric or addictive disorder that would preclude shared decision making
Clareo Health | A Decision Aid for Women With Early Stage Breast Cancer
